- Filed
- Jan 9, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2026 · Sep 30, 2025 | 70.5M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2024 | 15.96M sh |
| Capex | Q2 2026 · Sep 30, 2025 | $3K |
| Capex | Q2 2026 · Sep 30, 2024 | $21K |
| Operating Cash Flow | Q2 2026 · Sep 30, 2025 | −$4.44M |
| Operating Cash Flow | Q2 2026 · Sep 30, 2024 | $784K |
| Short Term Investments | Q2 2026 · Sep 30, 2025 | $5.8M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $8.78M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2025 | $3.84M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2024 | $2.46M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $368.98M |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $4.73M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $13.05M |
| Current Liabilities | Q2 2026 · Mar 31, 2025 | $7.49M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $14.17M |
| Total Liabilities | Q2 2026 · Mar 31, 2025 | $7.58M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $28.35M |
| Current Assets | Q2 2026 · Mar 31, 2025 | $9.66M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $383.17M |
| Total Assets | Q2 2026 · Mar 31, 2025 | $12.31M |
| Eps Diluted | Q2 2026 · Sep 30, 2025 | −$0.07 |
| Eps Diluted | Q2 2026 · Sep 30, 2024 | −$0.39 |
| Eps Basic | Q2 2026 · Sep 30, 2025 | −$0.07 |
| Eps Basic | Q2 2026 · Sep 30, 2024 | −$0.39 |
| Sga Expense | Q2 2026 · Sep 30, 2025 | $678K |
| Sga Expense restated | Q2 2026 · Sep 30, 2024 | $721K |
| Net Income | Q2 2026 · Sep 30, 2025 | −$4.63M |
| Net Income | Q2 2026 · Sep 30, 2024 | −$6.26M |
| Revenue | Q2 2026 · Sep 30, 2025 | $5.84M |
| Revenue | Q2 2026 · Sep 30, 2024 | $1.06M |